Mechanisms of Thrombus Formation
The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Abstract
Hemostasis is the process that maintains the integrity of a closed, high-pressure circulatory system after vascular damage. Vessel-wall injury and the extravasation of blood from the circulation rapidly initiate events in the vessel wall and in blood that seal the breach. Circulating platelets are recruited to the site of injury, where they become a major component of the developing thrombus; blood coagulation, initiated by tissue factor, culminates in the generation of thrombin and fibrin. These events occur concomitantly (Figure 1A; also see Video, available with the full text of this article at www.nejm.org), and under normal conditions, regulatory mechanisms contain . . .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These endothelial mediators subserve functions as varied as local flow distribution,91 immune surveillance (in concert with perivascular cells),92 and hemostatic balance.93”
In the citing paper
“Fibrinolytic therapy helps in dissolving fibrins in occluded vessels and improving the tumor vasculature [32,33,34,35,36].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [35]
In the citing paper
“enhanced platelet reactivity and acute thrombotic occlusion of vessels are the proximate cause of myocardial infarction, stroke and the majority of deaths in patients with CVD36.”
From Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential (2018) · cites this paper as [36]
Citations
Cites
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., & Chaudhuri, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9265 · Cited by 5,074
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Vu, T.-K. H., Hung, D. T., Wheaton, V. I., & Coughlin, S. R. (1991) · Cell · doi:10.1016/0092-8674(91)90261-v · Cited by 2,970
Platelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
An Enzyme Cascade in the Blood Clotting Mechanism, and its Function as a Biochemical Amplifier
MACFARLANE, R. G. (1964) · Nature · doi:10.1038/202498a0 · Cited by 1,119
Waterfall Sequence for Intrinsic Blood Clotting
Davie, E. W., & Ratnoff, O. D. (1964) · Science · doi:10.1126/science.145.3638.1310 · Cited by 1,113
The Roles of Protein C and Thrombomodulin in the Regulation of Blood Coagulation
Esmon, C. T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83649-3 · Cited by 1,046
Blood-borne tissue factor: Another view of thrombosis
Giesen, P. L. A., Rauch, U., Bohrmann, B., Kling, D., Roqué, M., Fallon, J. T., Badimon, J. J., Himber, J., Riederer, M. A., & Nemerson, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2311 · Cited by 991
Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Cotran, R. S., & Gimbrone, M. A. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.2.618 · Cited by 935
Research works printed but not linked: 4
- Semeraro N, 1983, Immunology, 50, 529
- Reinhardt C, 2008, J Clin Invest, 118, 1110
- Cho J, 2008, J Clin Invest, 118, 1123
- 1986, Lancet, 1, 397
Cited by
Items 101–200 of 1,000
Samama, M. M. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2010.09.008 · Cited by 163
“However, TF is also present in circulating blood, and this blood-borne TF plays an important role in the initiation of coagulation when vessel injury is limited to endothelial activation [9].”
BackgroundNanomaterials and nanomaterials-based drug delivery to promote cutaneous wound healing
Liu, T., Lu, Y., Zhan, R., Qian, W., & Luo, G. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114670 · Cited by 172
An intelligent DNA nanodevice for precision thrombolysis
Yin, J., Wang, S., Wang, J., Zhang, Y., Fan, C., Chao, J., Gao, Y., & Wang, L. (2024) · Nature Materials · doi:10.1038/s41563-024-01826-y · Cited by 164
Exosomes and stem cells in degenerative disease diagnosis and therapy
Chang, Y.-H., Wu, K.-C., Harn, H.-J., Lin, S.-Z., & Ding, D.-C. (2018) · Cell Transplantation · doi:10.1177/0963689717723636 · Cited by 159
Thrombomodulin: protectorate God of the vasculature in thrombosis and inflammation
Ito, T., & Maruyama, I. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04319.x · Cited by 159
Tompkins, C., Cheng, A., Dalal, D., Brinker, J. A., Leng, C. T., Marine, J. E., Nazarian, S., Spragg, D. D., Sinha, S., Halperin, H., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.056 · Cited by 159
“i o a i r t t t f p ormal hemostasis is dependent upon a series of complex, ell-regulated steps mediated by the vascular wall, platelets, nd the coagulation cascade (1).”
BackgroundAkhmedov, A. T., Sawamura, T., Chen, C., Kraler, S. C., Vdovenko, D., & Lüscher, T. F. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa770 · Cited by 170
Tissue Factor–Bearing Microparticles and Thrombus Formation
Zwicker, J. I., Trenor, C. C., Furie, B. C., & Furie, B. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.200964 · Cited by 156
“The central dogma of blood coagulation has been that (1) blood clotting is initiated through the action of tissue factor; (2) tissue factor is normally not exposed to blood; (3) tissue factor is constitutively expressed on the surface of nonvascular cells, including astrocytes, smooth muscle cells, epidermus, renal gl…”
Self-citationNew, S. E. P., & Aïkawa, E. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300128 · Cited by 168
“They participate in the pathogenesis of thromboembolic diseases, wherein the number of circulating procoagulant-microparticles increases greatly.(23) In the field of cancer research, exosomes, extracellular counterparts of endosomes, may enable invasive growth of tumor cells.”
BackgroundRubin, O., Delobel, J., Prudent, M., Lion, N., Kohl, K., Tucker, E. I., Tissot, J., & Angelillo‐Scherrer, A. (2012) · Transfusion · doi:10.1111/trf.12008 · Cited by 381
Qureshi, A. H., Chaoji, V., Maiguel, D. A., Faridi, M. H., Barth, C. J., Salem, S. M., Singhal, M., Stoub, D. G., Krastins, B., Ogihara, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007627 · Cited by 165
“Platelets also play a central role in cardiovascular diseases, cancer, and stroke, which account for the major mortality and morbidity in the United States [1,2].”
InfluentialYoung, A., Chapman, O., Connor, C., Poole, C., Rose, P., & Kakkar, A. K. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.106 · Cited by 150
Metabolic Plasticity in Resting and Thrombin Activated Platelets
Ravi, S., Chacko, B. K., Sawada, H., Kramer, P. A., Johnson, M. S., Benavides, G. A., O’Donnell, V. B., Marques, M. B., & Darley-Usmar, V. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123597 · Cited by 157
Targeting factor Xa and thrombin: impact on coagulation and beyond
Esmon, C. T. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-09-0730 · Cited by 149
“Blood-borne TF has been identified on microparticles derived from leukocytes and other cell types that are involved in the initiation of coagulation when vessel injury is limited to endothelial activation (11, 12).”
BackgroundRadiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT
Zhou, Y., Chakraborty, S., & Liu, S. (2011) · Theranostics · doi:10.7150/thno/v01p0058 · Cited by 158
“In fact, the plaque rupture is responsible for 76% of all fatal heart attacks caused by coronary thrombosis worldwide [187-190, 196-204].”
Mayne, E. S., Funderburg, N., Sieg, S. F., Asaad, R. J., Kalinowska, M., Rodriguez, B. A., Schmaier, A. H., Stevens, W. S., & Lederman, M. M. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182439355 · Cited by 156
“Platelet reactivity, especially within ruptured atheromatous plaques, has been implicated in the pathogenesis of atherothrombosis and cardiovascular disease.(1,2) Many agents aimed at preventing cardiovascular disease target platelet activation.”
BackgroundCyclic RGD functionalized liposomes encapsulating urokinase for thrombolysis
Zhang, N., Li, C., Zhou, D., Ding, C., Jin, Y., Tian, Q., Meng, X., Pu, K., & Zhu, Y. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.01.038 · Cited by 147
The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited
Dzobo, K., Senthebane, D. A., & Dandara, C. (2023) · Cancers · doi:10.3390/cancers15020376 · Cited by 146
Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles
Zhou, Z., Zhang, B., Wang, H., Yuan, A., Hu, Y., & Wu, J. (2018) · Theranostics · doi:10.7150/thno.27598 · Cited by 139
“These active ingredients can effectively increase endothelial cell numbers, optimize endothelial cell arrangements and increase endothelial cell tight junctions [44, 52-54].”
BackgroundLeukocyte Count and Intracerebral Hemorrhage Expansion
Morotti, A., Phuah, C., Anderson, C. D., Jessel, M. J., Schwab, K. M., Ayres, A. M., Pezzini, A., Padovani, A., Gurol, M. E., Viswanathan, A., et al. (2016) · Stroke · doi:10.1161/strokeaha.116.013176 · Cited by 154
Coagulation Abnormalities in the Trauma Patient: The Role of Point-of-Care Thromboelastography
González, E., Pieracci, F. M., Moore, E. E., & Kashuk, J. L. (2010) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0030-1265289 · Cited by 140
“Although this model supports traditional laboratory tests of coagulation by plasma-based algorithms, it does not correlate with current concepts of hemostasis occurring in vivo.(18) The two laboratory tests performed traditionally to assess coagulation are PT/INR and aPTT.”
BackgroundMethodCirculating Endothelial Microparticles in Diabetes Mellitus
Tramontano, A. F., Lyubarova, R., Tsiakos, J., Palaia, T. A., DeLeon, J. R., & Ragolia, L. (2010) · Mediators of Inflammation · doi:10.1155/2010/250476 · Cited by 152
“Plaque rupture and acute coronary thrombosis may also be associated with the activation of tissue factor from its encrypted form on MPs [10, 11].”
BackgroundZhang, F., Liu, Y., Lei, J., Wang, S., Ji, X., Liu, H., & Yang, Q. (2019) · Advanced Science · doi:10.1002/advs.201901378 · Cited by 148
Arellano‐Rodrigo, E., Álvarez‐Larrán, A., Reverter, J. C., Colomer, D., Villamor, N., Bellosillo, B., & Cervantes, F. (2008) · American Journal of Hematology · doi:10.1002/ajh.21338 · Cited by 140
Sabatine, M. S., Antman, E. M., Widimský, P., Ebrahim, I. O., Kiss, R. G., Saaiman, A., Polášek, R., Contant, C. F., McCabe, C. H., & Braunwald, E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61454-9 · Cited by 144
The biology of the platelet with special reference to inflammation wound healing and immunity
Nurden, A. T. (2018) · Frontiers in Bioscience · doi:10.2741/4613 · Cited by 134
“The latter catalyzes the transformation of Fg to the glue-like fibrin within the thrombus core where it promotes thrombus stability (17).”
BackgroundVenous thromboembolism in malignant gliomas
Jenkins, E., Schiff, D., Mackman, N., & Key, N. S. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03690.x · Cited by 142
“The mechanistic relationship between cancer and thrombogenesis has been extensively studied but remains incompletely understood [66,67].”
BackgroundRole of Tissue Factor in Venous Thrombosis
Manly, D. A., Boles, J. C., & Mackman, N. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-042210-121137 · Cited by 135
“Despite the fact that cultured ECs express TF after stimulation (15–17), evidence for TF expression by ECs in vivo is very limited (18–25).”
BackgroundInfluentialPlasma kallikrein: the bradykinin-producing enzyme
Björkqvist, J., Jämsä, A., & Renné, T. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-03-0258 · Cited by 135
“This cascade generates thrombin, which further activates platelets and converts plasma fibrinogen into fibrin that stabilises the clot (79).”
BackgroundThrombin Mediates Severe Neurovascular Injury During Ischemia
Chen, B., Cheng, Q., Yang, K., & Lyden, P. D. (2010) · Stroke · doi:10.1161/strokeaha.110.584920 · Cited by 135
Fibrin-Targeted and H 2 O 2 -Responsive Nanoparticles as a Theranostics for Thrombosed Vessels
Kang, C., Gwon, S., Song, C., Kang, P. M., Park, S., Jeon, J., Hwang, D. W., & Lee, D. (2017) · ACS Nano · doi:10.1021/acsnano.7b02308 · Cited by 136
Ojo, S. A., Lateef, A., Azeez, M. A., Oladejo, S. M., Akinwale, A. S., Asafa, T. B., Yekeen, T. A., Akinboro, A., Oladipo, I. C., Kana, E. B. G., et al. (2016) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2016.2559161 · Cited by 133
“Formation of thrombus (blood clots) in the blood circulatory system can cause considerable damage through blockage of cardiovascular system and ultimately death [48].”
BackgroundTruelove, E., Fielding, A. K., & Hunt, B. J. (2012) · Leukemia · doi:10.1038/leu.2012.290 · Cited by 133
Hippisley‐Cox, J., & Coupland, C. A. C. (2011) · BMJ · doi:10.1136/bmj.d4656 · Cited by 132
“Furthermore, our findings cannot offer hypotheses on individual mechanisms in the genesis of thromboembolism for comorbid conditions or individual drugs. For some clinical conditions (such as cancer), biological mechanisms have already been proposed.”
BackgroundLinks between atherosclerotic and periodontal disease
Chistiakov, D. A., Orekhov, A. N., & Bobryshev, Y. V. (2016) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2016.01.006 · Cited by 148
Control of Blood Coagulation by Hemocompatible Material Surfaces—A Review
Kuchinka, J., Willems, C., Telyshev, D. V., & Groth, T. (2021) · Bioengineering · doi:10.3390/bioengineering8120215 · Cited by 145
“However, the TF:FVIIa complex also activates FIX to FIXa which is part of the intrinsic coagulation pathway [79,80].”
BackgroundRevisited role of microparticles in arterial and venous thrombosis
Lacroix, R., Dubois, C., Leroyer, A. S., Sabatier, F., & Dignat‐George, F. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12268 · Cited by 130
Kim, J. Y., Ryu, J. H., Schellingerhout, D., Sun, I., Lee, S.-K., Jeon, S., Kim, J., Kwon, I. C., Nahrendorf, M., Ahn, C.-H., et al. (2015) · Theranostics · doi:10.7150/thno.11679 · Cited by 129
“Then, fibrin-targeting peptides used in the EP-2104R[11] (3.5 mg) were dissolved in 0.4 mL dimethyl sulfoxide (Sigma-Aldrich) with 1-ethyl-3-(3-dimethylaminopropyl) carbodi car-bodiimide hydrochloride (Sigma-Aldrich, 0.5 mg) and n-hydroxy succinimide (0.5 mg; GE Healthcare, Pis-cataway, NJ), while being vigorously sti…”
InfluentialNonthrombogenic Approaches to Cardiovascular Bioengineering
Li, S., & Henry, J. J. D. (2011) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071910-124733 · Cited by 141
The non-haemostatic role of platelets in systemic lupus erythematosus
Linge, P., Fortin, P. R., Lood, C., Bengtsson, A. A., & Boilard, É. (2018) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2018.38 · Cited by 142
Inflammation in venous thromboembolism: Cause or consequence?
Saghazadeh, A., Hafizi, S., & Rezaei, N. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.07.044 · Cited by 128
“Thrombus formation (reviewed by [13]) accompanies sequences of inflammatory events, that involve many immune and non-immune markers.”
BackgroundFuture research directions to improve fistula maturation and reduce access failure
Hu, H., Patel, S., Hanisch, J. J., Santana, J. M., Hashimoto, T., Bai, H., Kudze, T., Foster, T. R., Guo, J., Yatsula, B. A., et al. (2016) · Seminars in Vascular Surgery · doi:10.1053/j.semvascsurg.2016.08.005 · Cited by 140
“Blood, flow and the vessel wall, components of Virchow’s triad, are traditionally considered to be the three critical components of thrombosis [81].”
Jung, E., Kang, C., Lee, J., Yoo, D., Hwang, D. W., Kim, D., Park, S., Lim, S. K., Song, C.-G., & Lee, D. (2017) · ACS Nano · doi:10.1021/acsnano.7b06560 · Cited by 127
Role of flavonoids in thrombotic, cardiovascular, and inflammatory diseases
Vazhappilly, C. G., Ansari, S. A., Al-Jaleeli, R., Al-Azawi, A. M., Ramadan, W. S. H., Menon, V., Hodeify, R. F., Siddiqui, S. S., Merheb, M. M., Matar, R., et al. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00612-6 · Cited by 140
“This condition characterized by excessive thrombus formation will lead to partial or total blockage of blood vessels (Furie and Furie 2008).”
BackgroundKenawy, H. I., Boral, I., & Bevington, A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00215 · Cited by 136
“Subsequently, platelets will be activated at the injury site by thrombin and collagen (89), releasing FV that becomes activated by thrombin on the platelet surface (see Figure 1).”
BackgroundCoppin, L., Sokal, E. M., & Stéphenne, X. (2019) · Cells · doi:10.3390/cells8101160 · Cited by 127
“However, when they bind and fuse with activated platelets via a mechanism involving P-selectin glycoprotein ligand-1 on the microparticles and P-selectin on the platelets, they initiate coagulation [11].”
BackgroundBiomimetic fibrin-targeted and H2O2-responsive nanocarriers for thrombus therapy
Zhao, Y., Xie, R., Yodsanit, N., Ye, M., Wang, Y., & Gong, S. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100986 · Cited by 128
Involvement of microparticles in diabetic vascular complications
Tsimerman, G., Roguin, A., Bachar, A., Melamed, E. A., Brenner, B., & Aharon, A. (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-11-0712 · Cited by 134
Small bite, large impact–saliva and salivary molecules in the medicinal leech, Hirudo medicinalis
Hildebrandt, J., & Lemke, S. (2011) · Die Naturwissenschaften · doi:10.1007/s00114-011-0859-z · Cited by 147
“cleaves fibrinogen, which is a soluble pro-protein circulating in blood plasma, to generate short fibrin molecules which subsequently polymerize and form an insoluble meshwork of fibrin fibers (Furie and Furie 2008).”
BackgroundInfluentialCOVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response
Jayarangaiah, A., Kariyanna, P. T., Chen, X., Jayarangaiah, A., & Kumar, A. (2020) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029620943293 · Cited by 135
“Platelet adhesion at the site of injury occurs via interactions of glycoprotein VI to exposed collagen and glycoprotein Ib-V-IX with collagen-bound von Willebrand factor (vWF).(17) Platelet activation is initiated following this interaction.”
BackgroundInfluentialBorissoff, J. I., Otten, J. J. T., Heeneman, S., Leenders, P. J. A., van Oerle, R., Soehnlein, O., Loubele, S. T. B. G., Hamulyák, K., Hackeng, T. M., Daemen, M. J. A. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055784 · Cited by 131
Cell-Derived Microparticles in the Pathogenesis of Cardiovascular Disease: Friend or Foe?
Tushuizen, M. E., Diamant, M., Sturk, A., & Nieuwland, R. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.200998 · Cited by 123
Sauter, R. J., Sauter, M., Reis, E. S., Emschermann, F. N., Nording, H., Ebenhöch, S., Kraft, P., Münzer, P., Mauler, M., Rheinlaender, J., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.034600 · Cited by 120
Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage
Yougbaré, I., Lang, S., Yang, H., Chen, P., Zhao, X., Tai, W.-S., Zdravic, D., Vadasz, B., Li, C., Piran, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77820 · Cited by 132
“Bleeding usually occurs when the blood vessel is injured (45–47).”
Microparticles, thrombosis and cancer
Aharon, A., & Brenner, B. (2009) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2008.11.002 · Cited by 133
The molecular basis of thrombolysis and its clinical application in stroke
Murray, V., Norrving, B. G., Sandercock, P. A., Terént, A., Wardlaw, J. M., & Wester, P. O. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02205.x · Cited by 131
Factor XI and XII as antithrombotic targets
Müller, F., Gailani, D., & Renné, T. (2011) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283497e61 · Cited by 120
Flavonoids improve type 2 diabetes mellitus and its complications: a review
Yi, X., Dong, M., Guo, N., Tian, J., Lei, P., Wang, S., Yang, Y., & Shi, Y. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1192131 · Cited by 132
“As excessive foam cells form, the fiber cap thins and ruptures, leading the recruitment of circulating platelets to the wounded site and stimulating the synthesis of thrombin and fibrin, resulting in thrombosis and the development of various arterial illnesses such as myocardial infarction and stroke (47).”
BackgroundEffect of the mitral valve on diastolic flow patterns
Seo, J.-H., Vedula, V., Abraham, T. P., Lardo, A. C., Dawoud, F., Luo, H., & Mittal, R. (2014) · Physics of Fluids · doi:10.1063/1.4904094 · Cited by 117
Coagulation and metastasis: what does the experimental literature tell us?
Gil‐Bernabé, A. M., Lucotti, S., & Muschel, R. J. (2013) · British Journal of Haematology · doi:10.1111/bjh.12381 · Cited by 114
“434 ª 2013 John Wiley & Sons Ltd British Journal of Haematology, 2013, 162, 433–441 The extrinsic pathway of coagulation is initiated by exposure of TF to the endothelial layer by trauma (Furie & Furie, 2008).”
BackgroundPlatelets Are Not Just for Clots
McFadyen, J. D., & Kaplan, Z. (2015) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2014.11.006 · Cited by 135
“The hemostatic function of platelets is of fundamental importance in order to maintain the integrity of a closed, high-pressure circulatory system [1].”
BackgroundThe Physiology of Wound Healing: Injury Through Maturation
Teller, P., & White, T. K. (2009) · Surgical Clinics of North America · doi:10.1016/j.suc.2009.03.006 · Cited by 120
“Thrombin interacts with a receptor on the platelet surface (Par1) and leads to the release of ADP, serotonin, and thromboxane A2.(5) These substances enhance platelet aggregation.”
InfluentialCell-derived microvesicles and cancer.
van Doormaal, F. F., Kleinjan, A., Nisio, M. D., Buller, H. R., & Nieuwland, R. (2009) · PubMed · Cited by 146
Role of Fibrinolytic Enzymes in Anti-Thrombosis Therapy
Altaf, F., Wu, S., & Kasim, V. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.680397 · Cited by 118
“Furthermore, thromboxance A2 (TXA2) acts as a positive feedback regulator that activates and recruits more platelets to the main hemostatic plug (Furie and Furie, 2008; Reininger Armin et al., 2010; Lippi et al., 2011).”
BackgroundNanoparticles and The Blood Coagulation System. Part I: Benefits of Nanotechnology
Ilinskaya, A. N., & Dobrovolskaia, M. A. (2013) · Nanomedicine · doi:10.2217/nnm.13.48 · Cited by 114
Induruwa, I., Moroi, M., Bonna, A., Malcor, J.-D. M., Howes, J., Warburton, E. A., Farndale, R. W., & Jung, S. M. (2017) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13919 · Cited by 125
Microparticles in Health and Disease
Herring, J. M., McMichael, M. A., & Smith, S. A. (2013) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.12128 · Cited by 123
Duffy, D. M. (2010) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2009.01469.x · Cited by 112
Jagadeeswaran, P., Cooley, B. C., Gross, P. L., & Mackman, N. (2016) · Circulation Research · doi:10.1161/circresaha.115.306823 · Cited by 119
PlateletWeb: a systems biologic analysis of signaling networks in human platelets
Boyanova, D., Nilla, S., Birschmann, I., Dandekar, T., & Dittrich, M. T. (2011) · Blood · doi:10.1182/blood-2011-10-387308 · Cited by 120
Rootman, D. B., Heran, M. K. S., Rootman, J., White, V. A., Luemsamran, P., & Yücel, Y. H. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-304460 · Cited by 110
Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events
Radu, C. M., Spiezia, L., Gavasso, S., Fadin, M., Woodhams, B. J., Vettor, R., Campello, E., Zabeo, E., & Simioni, P. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-02-0156 · Cited by 110
“endotoxin, TNFα, and CD40 ligand), tissue factor expression on monocytes and the activated endothelium, and circulating TF–bearing MP (14).”
BackgroundAn update on etiology, prevention, and therapy of postthrombotic syndrome
Henke, P. K., & Comerota, A. J. (2010) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2010.08.050 · Cited by 115
Nie, C., Yang, Y., Cheng, C., Ma, L., Deng, J., Wang, L., & Zhao, C. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.01.027 · Cited by 113
Near-infrared off-on fluorescence probe activated by NTR for in vivo hypoxia imaging
Zheng, J., Shen, Y., Xu, Z., Yuan, Z., He, Y., Wei, C., Er, M., Yin, J., & Chen, H. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.08.014 · Cited by 108
The quest for blood-compatible materials: Recent advances and future technologies
Hedayati, M., Neufeld, M. J., Reynolds, M. M., & Kipper, M. J. (2019) · Materials Science and Engineering R Reports · doi:10.1016/j.mser.2019.06.002 · Cited by 113
Kwon, S.-P., Jeon, S., Lee, S., Yoon, H. Y., Ryu, J. H., Choi, D., Kim, J. Y., Kim, J.-W., Park, J. H., Kim, D., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.017 · Cited by 107
“When the vessel wall or endothelium is damaged, thrombus formation is induced by the interaction between collagen and tissue factor in the blood [2].”
BackgroundMulti-Constituent Simulation of Thrombus Deposition
Wu, W., Jamiolkowski, M. A., Wagner, W. R., Aubry, N., Massoudi, M., & Antaki, J. F. (2017) · Scientific Reports · doi:10.1038/srep42720 · Cited by 106
“loyed in Sorensen's model were available from the experimental literature or by calibration with experimental data. However, this model has several shortcomings limiting its versatility, namely: (1) it limits platelet deposition to an idealized, unchanging surface-fluid boundary and does not account for alteratio…”
InfluentialEvaluation of Soluble P-Selectin as a Marker for the Diagnosis of Deep Venous Thrombosis
Ramacciotti, E., Blackburn, S. A., Hawley, A. E., Vandy, F. C., Ballard-Lipka, N., Stabler, C., Baker, N., Guire, K. E., Rectenwald, J. E., Henke, P. K., et al. (2011) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029611405032 · Cited by 105
“They are rich in TF and other procoagulant factors that facilitate and magnify coagulation in the presence of thrombus.(18,19) Recent studies have investigated the role of procoagulant MP formation in regards to the inflammatory component of venous thrombosis.”
BackgroundWisman, P. P., Roest, M., Asselbergs, F. W., de Groot, P. G., Moll, F. L., van der Graaf, Y., & de Borst, G. J. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12538 · Cited by 108
The Mast Cell, Contact, and Coagulation System Connection in Anaphylaxis
Guilarte, M., Sala-Cunill, A., Luengo, O., Labrador‐Horrillo, M., & Cardona, V. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00846 · Cited by 104
“Hemostasis is maintained by complicated interactions between the coagulation and fibrinolytic systems as well as platelets and vessel walls (39).”
BackgroundThe Role of Physical Therapies in Wound Healing and Assisted Scarring
Fernández-Guarino, M., Bacci, S., Pérez-González, L. A., Martínez, M. B., Cecilia-Matilla, A., & Hernández‐Bule, M. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087487 · Cited by 104
“Next, secondary hemostasis produces the activation of the coagulation cascade [17].”
BackgroundMoganasundram, S., Hunt, B. J., Sykes, K., Holton, F., Parmar, K., Durward, A., Murdoch, I. A., Austin, C. B., Anderson, D. R., & Tibby, S. M. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181cd6d20 · Cited by 111
“In addition, the importance of platelet-fibrinogen interactions in thrombus formation is well appreciated, with a growing appreciation of the complexity of this relationship.(28,29) Bleeding risk secondary to hypofibrinogenemia will likely be increased with concurrent thrombocytopenia,(26) which was a common finding i…”
BackgroundHabets, K. L. L., Huizinga, T. W. J., & Toes, R. E. M. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12101 · Cited by 114
Thiol Isomerases in Thrombus Formation
Furie, B., & Flaumenhaft, R. C. (2014) · Circulation Research · doi:10.1161/circresaha.114.301808 · Cited by 108
“The blood coagulation cascade has been analyzed in vitro by initiating this process with exogenous tissue factor—to turn on the extrinsic pathway—or with kaolin or a similar substance—to activate the intrinsic pathway.(15) Similarly, platelet activation has been studied in vitro by the addition of various agonists, in…”
Self-citationApplications of Nickel-Titanium Alloy
Sharma, N., Jangra, K., & Raj, T. (2015) · Journal of Engineering & Technology · doi:10.4103/0976-8580.149472 · Cited by 102
Zhu, Z., Gao, Q., Long, Z., Huo, Q., Ge, Y., Vianney, N., Daliko, N. A., Meng, Y., Qu, J., Chen, H., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.01.025 · Cited by 130
“Based on the mechanism of surface-induced thrombosis, various kinds of approaches through surface modification have been explored so as to solve these problems timely and effectively [13].”
BackgroundNew insights into the spatiotemporal localization of prothrombinase in vivo
Ivanciu, L., Krishnaswamy, S., & Camire, R. M. (2014) · Blood · doi:10.1182/blood-2014-03-565010 · Cited by 100
“The resulting series of proteolytic activation steps on the surface of activated cells culminates in thrombin formation and the conversion of soluble fibrinogen to insoluble fibrin.(1) Binding of clotting factors tomembranes facilitates assembly of the intrinsic Xase and prothrombinase enzyme complexes and profoundly…”
BackgroundMoll, F. L., Baumgärtner, I., Jaff, M. R., Nwachuku, C., Tangelder, M. J. D., Ansel, G. M., Adams, G. L., Zeller, T., Rundback, J. H., GROSSO, M. A., et al. (2018) · Journal of Endovascular Therapy · doi:10.1177/1526602818760488 · Cited by 105
“Restenosis and loss of patency following EVT is largely a consequence of catheterinduced damage to the endothelium resulting in the eventual activation of both platelets and coagulation factors.(9,10) Attempts have been made in the past to target both platelets and fibrin with limited or no success; treatment with 250…”
BackgroundParadoxical Effect of Nonphysiological Shear Stress on Platelets and v on W illebrand Factor
Chen, Z., Mondal, N. K., Ding, J., Koenig, S. C., Slaughter, M. S., & Wu, Z. J. (2015) · Artificial Organs · doi:10.1111/aor.12606 · Cited by 100
Concurrent Diseases and Conditions in Dogs with Splenic Vein Thrombosis
LAURENSON, M. P., Hopper, K., Herrera, M. A. C., & Johnson, E. G. (2010) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2010.0593.x · Cited by 99
“Both exogenous and endogenous corticosteroids have prothrombotic effects, including increased coagulation factor levels such as factor VIII and von Willebrand’s factor levels, in addition to decreased AT levels.a,27,28,31,32 Cushing’s syndrome in people is associated with an increased risk of thromboembolism of 4 time…”
BackgroundApproaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis
Subhan, M. A., Parveen, F., Filipczak, N., Yalamarty, S. S. K., & Torchilin, V. P. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13030389 · Cited by 98
A biomimetic platelet based on assembling peptides initiates artificial coagulation
Yang, P., Zhang, K., He, P.-P., Fan, Y., Gao, X. J., Gao, X., Chen, Z., Hou, D., Li, Y., Yi, Y., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz4107 · Cited by 98
Harish, B. S., Uppuluri, K. B., & Veerappan, A. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.06.069 · Cited by 97
Anti-thrombotic technologies for medical devices
Lavery, K., Rhodes, C., McGraw, A. P., & Eppihimer, M. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.07.008 · Cited by 102
Osteocalcin: A Multifaceted Bone-Derived Hormone
Karsenty, G. (2023) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-061121-091348 · Cited by 108
“Carboxylation is a posttranslational modification operated by the enzyme gamma carboxylase in the presence of vitamin K as a cofactor (17).”
BackgroundGrowth factors and growth factor gene therapies for treating chronic wounds
Mullin, J. A., Rahmani, E., Kiick, K. L., & Sullivan, M. O. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10642 · Cited by 103
“…such as endothelin, secreted by damaged endothelium, resulting in constriction of the blood vessels and preventing further bleeding; 29 however, this process provides only a short-term remedy, since wound-induced hypoxia and acidosis result in muscle relaxation and subsequent…”
BackgroundChowdary, P., Carcao, M. D., Kenet, G., & Pipe, S. W. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02139-1 · Cited by 113
Platelet 12-LOX is essential for FcγRIIa-mediated platelet activation
Yeung, J., Tourdot, B. E., Fernandez‐Perez, P., Vesci, J., Ren, J., Smyrniotis, C. J., Luci, D. K., Jadhav, A., Simeonov, A. M., Maloney, D. J., et al. (2014) · Blood · doi:10.1182/blood-2014-05-575878 · Cited by 97
MYERSON, J., HE, L., LANZA, G., TOLLEFSEN, D., & WICKLINE, S. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04339.x · Cited by 96
Metadata
- Authors
- Furie, B., & Furie, B. C.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- ORCID
- Furie, Bruce
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-08-28
- Volume
- 359
- Issue
- 9
- Pages
- 938-949
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1983760732
- Cited by
- 1,926
- References
- 122
- Citations by year
- 2026: 75 · 2025: 119 · 2024: 114 · 2023: 121 · 2022: 110 · 2021: 117 · 2020: 103 · 2019: 96 · 2018: 93 · 2017: 109 · 2016: 108 · 2015: 122 · 2014: 101 · 2013: 119 · 2012: 106
- FWCI
- 13.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL087203)
- Topics
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Keywords
- thrombus formation, hemostasis, platelet recruitment, coagulation, tissue factor, thrombin, fibrin, vascular injury, coagulation regulation
- MeSH terms
- Animals, Blood Coagulation, Blood Coagulation Disorders, Fibrinolytic Agents, Humans, Neoplasms, Thrombosis, Platelet Activation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.